Faculty of Medicine

What's New in Research Funding

Molecular structuresPage last updated April 17, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates

 

April 17, 2019
 

  • CIHR Message from the President: Final decision on the Foundation Grant program. CIHR has decided to sunset the Foundation Grant program. CIHR conducted a number of analyses of all completed Foundation Grant competitions, which revealed four main areas of concern: gender, age, institution size, and pillar of research. 
     
  • University College London - University of Toronto Call for Collaborative Activities Proposals. University College London (UCL) and the University of Toronto (UofT) are contributing matching funds to support collaborative education and research initiatives through a joint call for proposals for the development of collaborative activities. Projects must include research team participants from both UofT and UCL. The UCL collaborator must be from one the following three faculties: UCL Faculty of Life Sciences, UCL Faculty of Arts & Humanities and UCL Faculty of Law. U of T applicants must have a faculty appointment with UofT. 
    Funding: CAD $17,000 to support UofT-funded researchers; £10,000 to support UCL-funded researchers. Duration: One year, beginning May 31, 2019.
    Deadline for applications: April 30, 2019.  
     
  • Innovation for Defence Excellence and Security (IDEaS): Program Information Session. We invite you to attend an information session for the Innovation for Defence Excellence and Security (IDEaS) program hosted by Eric Fournier, Director General for the IDEaS program at the Department of National Defence (DND). DND is investing $1.6 billion over the next 20 years into the IDEaS program to provide the Canadian Armed Forces (CAF) and Canada’s defense and security communities with unique and innovation solutions to the pressing defence and security challenges of tomorrow. Funding opportunities exist for projects at all technology readiness levels. Visit here for more information about upcoming IDEaS funding opportunities.
    Date: Monday​​​, April 29, 2019 from 9am - 10:30am
    Location: Bahen Centre, Room 1220. Please RSVP by April 22 to engineering.partnerships@utoronto.ca
     
  • MacArthur Foundation 100&Change Program. The MacArthur Foundation has launched the second round of the 100&Change competition, a competition for a single $100 million grant to fund proposals that promise real and measurable progress in solving a critical problem of our time.100&Change proposals require the articulation of both a problem and its solution.  Competitive proposals will address a significant problem and provide a solution that is impactful, evidence-based, feasible, and durable with demonstrated significant and authentic engagement with affected communities. In response to this opportunity, the Division of the Vice-President, Research & Innovation (VPRI) is inviting interested parties from the U of T community to propose a project or initiative for consideration. Initial proposal summaries of 500 words or less should be submitted to vp.research@utoronto.ca before Tuesday, April 30.  The VPRI and the Division of University Advancement are coordinating efforts to support development of competitive proposals for this program.  Researchers are invited to contact Steven Hermans, Partnership Development Officer, to discuss the program and any potential proposal.
    To learn more about the program, please visit the MacArthur Foundation’s 100&Change website and the resources for applicants.    
     
  • Genome Canada: Genomic Applications Partnership Program (GAPP) - Round 16. Precision Health Initiative - Rare Diseases: Clinical Implementation Projects. Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. Round 16 is now open and Genome Canada is encouraging the submission of projects to the GAPP. For more details, please see here. For more information on the application process, please visit the GAPP homepage, or the UofT funding opportunityDraft EOI is due to RSO and Ontario Genomics on May 21, 2019 at 12 noon.
     
  • Canadian Foundation for Healthcare Improvement (CFHI): Priority Health Innovation Challenge - Early Innovator Award. The objective of this Challenge is to identify teams and grow promising innovations in two shared health priorities: 1). Improving access to mental health and addictions services; 2). Home and community care. Federal, provincial, and territorial governments have made 12 common indicators focused on measuring pan-Canadian access to these health priorities. Amount: Up to $400,000. Register now. Applications are accepted on a rolling basis until October 20, 2020.
    Early Innovator Award: 
    Upon successful registration, qualifying Teams may submit a video that introduces their team leader, patient and/or family representative, senior officer or director endorsing the work, and demonstrates: a) their current work underway relevant to their chosen indicator(s), and b) their intended aim and anticipated outcomes. Videos must meet the requirements named on page 5 of the official terms. Video deadline: May 10, 2019.
     
  • Brain Canada Foundation and the Barbara Turnbull Foundation for Spinal Cord Research: 2019 Spinal Turnbull-Tator Award in Spinal Cord Injury and Concussion Research. This award aims to recognize an outstanding publication by a Canadian researcher in the field of spinal cord and brain injury research (including concussion) in the last two years with a $50,000 prize. Applicants will need to demonstrate that their publication includes novel and ground-breaking results that represent a major advancement for the research area and has the potential to generate new hypotheses. The award is open to all active investigators in any phase of their career, graduate students, and postdoctoral fellows conducting research at a Canadian institution. Deadline for applications: May 20, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • The Longitude Prize - Antimicrobial Resistance (AMR). The prize aims to support the development of a transformative point-of-care test for antimicrobial resistance (AMR) that is rapid and accurate. This is a £10 million (approximately $17.3M CAD) Challenge Prize competition to support tests that impact treatment decisions to significantly reduce misuse or overuse of antibiotics and conserve antibiotics for future generations. Once the product is being produced at full scale manufacture, the test must be affordable for purchase and use in its intended global market(s), and the time from sample collection to reporting of the result must be less than thirty minutes. There are currently 83 teams competing in the Challenge from 14 countries, including a combination of established private companies, groups from academic institutions and start-ups. Deadline: Applications can be submitted at any time, but they will only be reviewed and assessed every four months: 31 January, 31 May, 30 September. The prize will close if and when a suitable winner is found. The last application deadline, if no winner has been found before then, will be 30 December 2020.

  • Alzheimer's Drug Discovery Foundation: Diagnostics Accelerator - Digital Biomarkers. The Diagnostics Accelerator supports research and development through translational research awards and access to consulting support from industry experts. The current RFP is soliciting projects to develop and validate digital biomarkers for Alzheimer's disease and related dementias. Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected, measured and analyzed by means of digital devices such as portables, wearables, or ambient sensors. Digital biomarkers range from computerized or app-based versions of traditional neurocognitive tests to novel technology platforms that combine multiple complex data sources into a phenotypic signature. Proposals addressing a range of potential clinical uses are of interest, especially technologies for early assessment and those aiding in diagnosis and monitoring treatment response or rate of disease progression. Creative approaches to leverage new and existing software and hardware are encouraged. Deadline for Letters of Intent: June 7, 2019. Three stages of projects will be supported through this call:
    • Exploratory Awards: Amount: Approximately $250,000.
    • Proof-of-Principle Awards: Amount: Approximately $500,000.
    • Validation Awards: Amount: Will be based on the stage and scope of research.
       
  • amFAR: Mathilde Krim Fellowships in Biomedical Research. The goal of amfAR’s Mathilde Krim Fellowships in Biomedical Research is to: 1). Facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic institution or nonprofit organization; 2). Support two years of postdoctoral biomedical research (phase I); 3). Provide the possibility of one additional year of research funding during the first year of an independent research position (phase II). Amount: Up to USD $150,000 over two years. Registration deadline: May 17, 2019; Application deadline: May 22, 2019.
     
  • Worldwide Cancer Research: Research Grants. Worldwide Cancer Research provides funding for basic and translational research into the prevention, diagnosis or treatment of cancer. They do not prioritize any field of research within this, and welcome research that draws on epidemiological, behavioural and clinical data to provide a starting point for a new avenue of research.  Multidisciplinary or discipline-hopping projects are encouraged where this helps stimulate innovation Amount: Up to £250,000 over 3 years. Deadline for applications: May 3, 2019. 
     
  • American Heart Association and Amazon Web Services Data Grant Portfolio 4.0 - Artificial Intelligence and Machine Learning Grants. The purpose of this RFA is to test and refine artificial intelligence and machine learning algorithms using learning health care system data and/or multiple longitudinal data sources to improve our understanding of all data related to precision medicine. Data source examples include but are not limited to: images, electronic health records, genetics and omic-related data, community engagement data (including social determinants of health), wearable devices, smart phone and other sensor related technology. Applicants are encouraged to use multiple sources of data, or longitudinal data to continue to refine algorithms. Amount: Up to USD $200,000 over 2 years. Deadline for applications: July 30, 2019.
     
  • Osteology Foundation: Osteology Researcher Grants. The Foundation offers two types of grants: Advanced Researcher Grants and Young Researcher Grants. The Young Researcher Grants programme supports young researchers in realizing their own research project and fuelling their research career. In both grant programmes clinically relevant questions shall be addressed and the results published open access in international peer-reviewed journals. These grants are intended for research proposals submitted by investigators who want to address questions in the field of oral and maxillofacial tissue regeneration. Amount: Up to CHF 30,000 for one year for Young Researcher Grants; and up to CHF 100,000 for up to two years for Advanced Researcher Grants. Deadline for abstract submissions: June 15, 2019.

April 10, 2019
 

  • International Doctoral Clusters: Building Impactful Research Alliances with Partner Academic Institutions. The University is pleased to invite those interested in learning more about how to initiate, launch and govern an International Doctoral Cluster with a partner academic institution. Issues like U of T support & governance, shared resources, academic mobility, among others will be explored.
    Providing insights will be:
     -Leah Cowan, Professor of Molecular Genetics and academic lead of the IDC with Zhejiang University
    -Ue-Li Pen, Professor of Astronomy & Astrophysics and academic lead of the IDC with the Max Planck Institute, Shanghai Jiao Tong University and the Tata Institute of Fundamental Research
    -Marc Cadotte, Professor of Biological Sciences, UTSC and academic lead of the IDC with University of Cape Town
    Date: Tuesday, April 16 from 2:30pm to 4pm 
    Location: Mayhal Engineering Building, Room 330.
    Please RSVP at international@utoronto.ca.
     
  • University of Toronto Early Stage Technology Program (UTEST). The UTEST Program is announcing its eighth call for UofT companies. UTEST provides UofT start-up companies with seed funding of up to $100,000 in the form of a SAFE, 12 months of incubation space, intense entrepreneurial education provided by MaRS, legal support, mentoring and business strategy support. Since 2012 UTEST companies have raised over $100M in investment funding with 3 acquisitions. Full program information and application can be found on the UTEST program pageDeadline for applications: May 23, 2019.
    Selected companies will be interviewed on May 30th and 31st. The program will begin the week of June 10th, 2019.
     
  • Molly Towel Perinatal Research Foundation: 2019 Grant Competition. the Foundation will support original and innovative research, which she defined as the pursuit of new information derived from basic biomedical or clinical research. High priority is given to projects that concern fetal growth or metabolism but any studies that involve original research in fetal or neonatal medicine will be considered. However, purely epidemiological research or clinical trials will not be considered. Deadline for applications: April 18, 2019.
     
  • Alzheimer's Association - 2019 Part the Cloud: Translational Research Funding for Alzheimer’s Disease (PTC). This new grant mechanism aims to fill the gap in Alzheimer’s disease drug development by providing support for early phase studies of potential Alzheimer’s therapeutics; this can include validation of biological markers of disease progression in the context of evaluating a potential therapy. They anticipate funding up to four (4) Part the Cloud Research Awards. Each grant is limited to USD $750,000 (direct and indirect costs) over two or three years. Deadline for Letters of Intent: May 23, 2019.
     
  • American Association for Cancer Research: AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice. The grants provide USD $400,000 over a two-year period. Deadline for Letters of Intent: May 10, 2019.
     
  • Craig H. Neilsen Foundation: Spinal Cord Injury Research on the Translational Spectrum (SCIRTS). The goal of the SCIRTS portfolio is to address gaps in the field and advance novel approaches to improving function and developing curative therapies after spinal cord injury. The scope of this program is broad, encompassing mechanistic, preclinical modeling, translational and/or clinical research. There are three funding categories in the SCIRTS portfolio: Postdoctoral Fellowships (up to USD $150,000 over 2 years), Pilot Research Grants (up to USD $300,000 over 2 years), and Senior Research Grants (up to USD $600,000 over 3 years). Deadline for Letters of Intent: May 6, 2019. 
     
  • Crohn's & Colitis Foundation: Litwin IBD Pioneers Initiative. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data. Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is open to investigators from other disciplines new to the IBD field, as well as countries outside the United States. There is no fixed upper or lower limit of funding, but awards are generally not funded above USD $130,000, including 10% indirect costs, for clinical trials; and above USD $110,000, including 10% indirect costs, for lab-based studies. Deadline for Letters of Intent: May 5, 2019.
     
  • Cystic Fibrosis FoundationPriority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF.
    • Pilot and Feasibility Awards. These awards are for developing and testing new hypotheses and/or methods, and supporting promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. Amount: Up to USD $50,000 per year (plus 8 percent for indirect costs) for up to 2 years. Applicants from outside the U.S. are welcome to apply.  Deadline for applications: May 13, 2019.
    • Research Grants. Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal, or patient levels. Amount: Up to USD $125,000 per year (plus 8 percent for indirect costs) for up to 2 years, at which time a grant may be competitively renewed for additional funding. Applicants from outside the U.S. are welcome to apply. Deadline for applications: May 13, 2019.
       
  • Epilepsy Foundation: My Brain Map Initiative. The Epilepsy Innovation Institute (Ei2) will be leading an effort to better define an individual’s brain network. They want to create a Google Map for your brain that highlights your unique brain traffic pattern. With this map, we can better identify the routes your seizure could take, where the potential traffic jams might be, and how activity can get re-routed in the brain during those situations. The purpose is to better define an individual’s brain network to enhance diagnosis and careEi2 is pleased to announce a Request for Proposals for the My Brain Map initiative to fund pilot studies (up to USD $200,000) that would propose novel exploratory ways to model seizure propagation in a personalized brain network model. Deadline for Letters of Intent: June 21, 2019.
     
  • Multiple Myeloma Research Foundation: Research Fellow Awards. The Research Fellow Awards are for researchers who hold a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow or assistant professor levels who are beginning studies in the multiple myeloma field under the supervision of a research mentor or sponsor. Applicants may request up to USD $75,000 for one year. Application deadline: June 24, 2019.

April 5, 2019
 

  • BBDC/HSRLCE Pilot and Feasibility Grant in Cardiovascular and Diabetes Research 2018. This competition is now open to both basic science and clinical research applications. All applicants and co-applicants must be members of either the BBDC or the HSRLCE. Further, principal applicants must have at least one co-applicant who is a member of a different Centre (e.g. if the PI is a member of HSRLCE, at least one co-applicant must be a member of the BBDC). The total non-renewable grant amount is $100,000 (to be spent over a maximum of 2 years). Deadline for applications: May 31, 2019 at 4pm.
     
  • Harrington Discovery Institute Scholar-Innovator Call for Proposals.  The award recognizes physician-scientists whose research has the potential to advance standard of care. The Harrington Scholar-Innovator Award provides funding, as well as hands-on drug development support, to help bridge the gap between basic discovery and clinical introduction. Physician-scientists are invited to submit an application. A Letter of Intent is not required this year. Up to twelve Harrington Scholar-Innovator awards are made each year through a competitive selection process. Amount: $100,000 guaranteed; opportunity for up to $700,000. UofT internal deadline for MRA: April 26, 2019: Sponsor deadline for applications: May 3, 2019.
     
  • Atomwise Inc. - Artificial Intelligence Molecular Screen (AIMS) Awards. This program is intended to broaden the pool of scientists involved in the discovery of small molecules for the treatment and investigation of human diseases. To advance this goal, Atomwise seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. This Artificial Intelligence Molecular Screen (AIMS) program is designed to dramatically accelerate the race towards life-saving drugs by analyzing millions of compounds for each disease. Contributing AI technology and delivering physical molecules to labs across the world, the program is the first of its kind. All researchers who apply for Atomwise’s AIMS Awards program will be considered for an AIMS Award, the RaD Discovery Award, the C4C Discovery Award, and the AIMS Innovator Award. Deadline for applications: April 29, 2019.
     
  • Asthma Canada - CAAIF Bastable-Potts and Goran-Enhorning Graduate Student Research Awards in Early-onset and Late-onset Asthma. The objective of the Graduate Student Research Awards  is to create value-added opportunities for the training, education, and professional development of graduate students, to ensure continued improvement of asthma treatment therapies and progress towards finding a cure for asthma. These are two Awards for PhD Students each with a value of $20,000. Deadline for applications: May 31, 2019.
     
  • BioCanRx: Bench to Bedside Translation of Innovative Cancer Therapeutics, Cycle II. The objective of this funding opportunity is to support project concepts that propose new research, enabling further develop of the current portfolio of assets, with an emphasis on cellular immunotherapies. Review the Project Portfolio here. The Cycle II research program will focus on extending immunotherapy successes in the clinic beyond initial responders. To address this challenge, while making use of technologies in the BioCanRx pipeline or by soliciting new complimentary technology, BioCanRx will invest in projects aimed at understanding patient and/or tumour type limitation(s) and proposing improved novel therapies, trials, or combination approaches to overcome the identified limitation(s). Amount: Applicants submit a budget and it is expected that each project will secure 50% of the total project funds from partners. Deadline for Letters of Intent: May 1, 2019.
     
  • Alex's Lemonade Stand; 'A' Awards - An early career research program. The 'A' Award is designed for the early independent career scientist who wants to establish a career in pediatric oncology research. The ideal candidate has an original project, can demonstrate outstanding career development support from the institution, and has a strong future commitment to pediatric cancer investigation. These awards are open to MD, MD/PhD and PhD applicants who are within 5 years of their first faculty appointment as an Assistant Professor. Amount:  USD $200,000 per year for four years, with the possibility of a fifth year of funding. Deadline for applications: May 20, 2019.
     

March 28, 2019
 

  • Canadian Cancer Society(CCS) and CIHR: CCS/CIHR Cancer Survivorship Team Grants.  The intent of this funding opportunity is to support new intervention research designed to mitigate the challenges experienced along the survivorship journey, as well as the evaluation and validation of existing interventions to assess their potential for implementation as best practices.The program goal will be achieved through the support of a network of multidisciplinary teams, each led by a nominated Principal Investigator and at least 2 co-Principal and/or co- Applicants, one of whom must be within their first five years as an independent researcher, drawn from at least 3 different regions of Canada (Atlantic Provinces, Central Canada, Prairie Provinces, West Coast, Northern Territories). 
    Survivorship WEBINAR: Monday, April 8th at 1pm EDT. Register here.
    Grant registration deadline: May 29, 2019; Full application deadline: September 10, 2019.
     
  • CIHR upcoming Team Grants.
  • UPDATE - The Physicians’ Services Incorporated (PSI) Foundation: Healthcare Research by Community Physicians. PSI is pleased to announce that they now accept applications for the Healthcare Research by Community Physicians funding stream from all community physicians, including those who have academic appointments and are residing in Ontario’s urban centres. Their website has been updated to reflect this change. Deadline for applications: Continuous.
     
  • Alberta Innovates: New Collaborations Program. This program is intended to encourage collaborations between researchers from an Alberta-based institution with researchers from institutions outside Alberta. Qualified investigators may seek funding for small research projects directly related to prion diseases and/or human neurodegenerative diseases and dementias where the etiology involves protein misfolding and the pathogenesis has prion-like characteristics. These grants will be held by at least two PIs who are from at least two different research institutions. One Alberta-based PI is to be identified as the nominated Principal Investigator. Amount: Up to $100,000 for a maximum for two years. Deadline for applications: Continuous. 
     
  • Association for Frontotemporal Degeneration (AFTD): AFTD Pilot Grants - Nonpharmacological Therapies and Tools for FTD Pilot Grant. AFTD Pilot Grants provide seed funding for innovative research projects in the preliminary stages of development with the potential to increase understanding and improve the diagnosis or treatment of frontotemporal degeneration (FTD) across the full spectrum of FTD disorders: behavioral variant FTD, primary progressive aphasia, progressive supranuclear palsy, corticobasal syndrome, and FTD-ALS. Upper amount: USD $60,000 for one year, direct costs only. Deadline for applications: April 12, 2019.
     
  • CHEST Foundation Grants. 2019 Requests for Proposals. Applicants must hold a CHEST membership at the time of application. Deadline for applications: April 22, 2019.
    • The GlaxoSmithKline Distinguished Scholar in Respiratory Health
    • CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency
    • Research Grant in Severe Asthma
    • Research Grant in Chronic Obstructive Pulmonary Disease
    • Research Grant in Cystic Fibrosis
    • Research Grant in Lung Cancer
    • Research Grant in Nontuberculous Mycobacteria Diseases
    • Research Grant in Pulmonary Arterial Hypertension
    • Research Grant in Pulmonary Fibrosis
    • John R. Addrizzo, MD, FCCP Research Grant in Sarcoidosis
    • Research Grant in Sleep Medicine
    • Research Grant in Venous Thromboembolism
    • Research Grant in Women’s Lung Health
       
  • Pfizer, Inc.: Requests for Proposals 
  • Chordoma Foundation: Requests for Proposals.
    • Drug Screening Program (NEW). The Foundation has developed a centralized Drug Screening Program to enable rapid and efficient evaluation of potential new treatments for chordoma in preclinical models of the disease. Through this service, academic researchers and companies can more easily evaluate promising drug candidates without the time and expense of acquiring, establishing and expanding preclinical models. Through this request for proposals, the Foundation aims to identify well-justified therapeutic concepts to evaluate in chordoma xenograft models through the Drug Screening Program in 2019. The primary intent of these studies is to generate preclinical data that can help validate new therapeutic targets and corresponding drug classes, and, ideally, provide evidence to justify or prioritize future clinical trials. Therefore, though all applications will be considered, priority will be given to drugs in clinical development or marketed agents. Deadline for proposals: May 10, 2019.
    • Clinical Trials Program (NEW). The Clinical Trials Program helps researchers and companies design, launch, and enroll patients in chordoma clinical trials. As part of this program, the Foundation supports well-justified clinical trials through grants of up to USD $300,000 to fund non-drug study costs for investigator-initiated trials, for patient education and outreach, and trial initiation assistance. Trial concepts may be proposed by industry or academic investigators. Deadline for concept papers/proposal: May 10, 2019.
       
  • US Department of Defense - Congressionally Directed Medical Research Programs: 2019 Program Opportunities.

 

March 20, 2019
 

  • The Michael R Freeman Innovation Award: Cardiac and Vascular Collaborative Innovation Competition (in collaboration with the Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), and  the academic/teaching hospitals from the Toronto Central Local Health Integration Network (TCLHIN)). The goal is to spur innovation and collaboration between institutes with the aim of improving quality of care within cardiac and vascular programs. The purpose of the award is to provide seed funding for novel ideas aimed at cardiovascular disease management, emphasizing collaborative research and development at multiple sites within the TCLHIN and initiated by at least one investigator from within the LHIN. Priority will be given to ideas with a pathway toward commercialization within 5 years. Read more.
    Funding Source/Details: 
    – Each of the seven participating sites (HSC, SMH, SHS, SHSC, UHN, UoT TBEP and WCH) will commit funds of $35,000 per site toward associated activities at their site. This will be matched by a $75,000 support by HSRLCE, to provide a potential total award pool of $300K per year. The total potential funding available per year is $300,000 based on multi-site participation in which the HSRLCE will match funds from participating sites with a ratio of 1:3 (HSRLCE: participating site funds).
    – The maximum award per successful proposal is $150,000.
    – Award term will be one year (awardees will have up to two years to spend the money). A second term of funding is possible with re-application and associated competitive review. 
    Deadline for applications: May 15, 2019. Contact: Liz Thuo, Business Manager, HSRLCE Tel: 416-978-2351, hsrl.centre@utoronto.ca.
     
  • Can-GARD (The Canadian Gene Cure Advanced Therapies for Rare Disease): Clinical and Research Fellowship in advanced genomics in paediatric rare disease. Can-GARD project and the Centre for Genetic Medicine (CGM), with support from the Division of Clinical and Metabolic Genetics at The Hospital for Sick Children (SickKids) in Toronto, Ontario, are seeking applications for a Clinical and Research Post-Doctoral Advanced Genomics in Paediatric Rare Disease Fellowship opportunity. Training location: SickKids. Applicants should hold a MD degree or equivalent and completed an accredited residency program. Applicants should be comfortable working in a paediatric medicine environment. Applicants from any specialty or subspecialty are welcome to apply. Deadline has been EXTENDED to March 30, 2019.
     
  • Arthritis Society: Funding Opportunities.
    • Strategic Operating Grants: Strategic Theme I: Improving our understanding of arthritis and finding the cure. Research under this theme will seek to improve our understanding of the causes of arthritis in order to develop new approaches to alleviate the pain, prevent and/or slow the progression of disease, restore joint function, and eventually cure those affected by arthritis. Amount: Up to $120,000 per year for up to 3 years. Deadline for LOIs: April 15, 2019
    • Arthritis Centre Grants. All proposals must support capacity building programs with an aim to increase the number of academic rheumatologists in Canada and/or to support research training in rheumatology. Amount: $15,000 for 1 year, or up to $150,000 for 1 year based on the number of partners.  Deadline for applications: April 15, 2019.
    • Star Career Development Awards. The salary and research funding represents a three year commitment by the Arthritis Society, together with an additional three year commitment by the applicant’s Host Institution. Abstract registration deadline: May 22, 2019; Application deadline: June 26, 2019.
       
  • Canadian Cancer Society (CCS): Impact Grants.  Impact Grants provide funding to support ideas that promote major advancements in research programs, whether at the fundamental discovery stage (such as studies involving model organisms that demonstrate potential for impact) through to applied research (such as patient or population-based proposals). Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, and social and population health research. The goal is to provide a mechanism for scientists to adopt innovations and accelerate the application of new knowledge to address problems in cancer research that have the potential for practical application. Amount: Up to $300,000 per year for up to 5 years to a maximum of $1.5 million. Deadline for LOIs: April 17, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • Michael J. Fox Foundation (MJFF): Therapeutic Pipeline Program. the Therapeutic Pipeline Program advances Parkinson's disease therapeutic and intervention development along the pre-clinical and clinical path (i.e., both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches). The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from non-PD indications. Amount: Up to USD $500,000 for pre-clinical or applied technology programs; up to $2 million for clinical programs.
    Visit here for other Open Targeted Funding Programs. 
    Deadline for preliminary proposals: April 19, 2019; Deadline for full proposals by invitation: July 15, 2019.
    INFORMATION WEBINAR: Monday, April 1, 2019 from 12pm-1pm ET. RSVP here.
     
  • Children's Heart Foundation (CHF): Congenital Heart Disease Research Grants. CHF seeks to fund life-saving, life-changing CHD research in clinical cardiology, basic science, population science, and advancement of surgical/interventional techniques. Amount: USD $100,000 for one year. International applicants are eligible. Deadline for applications: June 7, 2019.
     
  • Paris Institute of Advanced Study - Brain, Culture and Society. Applications are welcome from high level international scholars and scientists in the fields of the humanities, social sciences, cognitive sciences, and neurosciences for a research stay of five or ten months during the academic year 2020-2021 within the framework of its “Brain, Culture and Society program”. The Paris IAS gives its research fellows the unique opportunity to work freely on the project of their choice at the interface of neuroscience, the cognitive sciences and the humanities and social sciences. They benefit from the scientific environment of the Institute and receive support for creating contacts with researchers in the academic institutions of Greater Paris. 

March 5, 2019
 

  • Weston Brain Institute: Open Funding Opportunities.
    • Rapid Response Canada. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: Up to $300,000 over 18 months. 
      Parkinson's & Related Diseases: Program INFORMATION WEBINAR: April 3 at 1pm EST. Register hereEXTENDED deadline for LOI's: May 15, 2019 at 2pm EST; Full Proposals deadline: July 16, 2019.
      Alzheimer's & Related Diseases: Deadline for LOI's: April 1, 2019 at 2pm EST; Full Proposals deadline: July 30, 2019.
    • Transformational Research: Canada 2019. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: $200,000 to $1.5M over up to 3 years.
      Deadlines and INFORMATION WEBINARS are the same as the Rapid Response Canada opportunity listed above.
    • Big Ideas: Canada. Projects must have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging, and be led by Canadian Researchers. Amount available: $5M - $20M. Applications are accepted on a rolling basis.
    • Early Phase Clinical Trials: Canada. Projects must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination thereof to help accelerate the development of therapeutics for neurodegenerative diseases of aging. Amount: Up to $1,500,000 per project over up to 4 years. Applications are accepted on a rolling basis.
       
  • Linkage Tool for the Sepsis Research Network Initiative is now available. CIHR has launched a team grant for a sepsis research network. CIHR invites all interested researchers to complete a short survey to join the linkage tool for this competition. 
     
  • CIHR/KRESCENT: Early Career Investigators in Maternal, Reproductive, Child and Youth in Kidney Research. The RFA will be updated with the KRESCENT information in the next week or two. If you are interested in applying to this program, please begin preparing your application and there will soon be an option to pick the KRESCENT pool. The successful applicant in this competition will be able to take advantage of the KRESCENT curriculum and mentorship program. Registration deadline: April 2, 2019; Application deadline: May 14, 2019.
     
  • Workers Compensation Board (WBC) Manitoba: 2019 Research and Workplace Innovation Program. The WCB has created the Research and Workplace Innovation Program (RWIP) to promote and fund scientific research, workplace innovation, training and education projects and knowledge transfer related to prevention of occupational injuries, diseases and return to work of injured or ill workers. RWIP Projects are funded under three (3) streams: 1) Scientific Research, 2) Training and Education, and 3) Workplace Innovation. Amount: Up to $100,000 per year for up to two years. Deadline for Notice of Intents for Scientific Research: March 25, 2019. Application deadline for Scientific Research: May 27, 2019.
    Closing date for other funding streams: June 25, 2019.
     
  • Brain & Behavior Research Foundation: 2019 National Alliance for Research in Schizophrenia and Effective Disorders (NARSAD) Young Investigator Grant. Young Investigator Grants provide each scientist with up to $35,000 per year for two years totaling $70,000 to enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. All research must be relevant to our understanding, treatment and prevention of serious psychiatric disorders, such as: schizophrenia; bipolar; mood and anxiety disorders; and early onset brain and behavior disorders. Application deadline: March 19, 2019.
     
  • Canadian Institute for Military and Veteran Health Research. CIMVHR TPL Research Initiative. The Research Initiative encourages researchers from relevant fields to submit project proposals to compete for access to funding to accelerate research and improve the health and wellbeing of Canadian military, Veterans, and their families. This opportunity has been made possible through the support of True Patriot Love and the True Patriot Love Fund. The True Patriot Love Fund was established in January 2015 for the purposes of supporting research to discover new treatments, establish evidence-based programs, and increase access to programs and treatments dedicated to advancing the health and well-being of Canadian military members, Veterans, and their families. Deadline for proposals: April 12, 2019.
     
  • ADDF (Alzheimer's Drug Discovery Foundation)-Harrington Scholar Program. This program recognizes physicians or scientists who are doing research to develop drugs to prevent, treat and cure Alzheimer’s disease. The award provides funding and drug development support to help bridge the gap between basic discovery and the clinical realm. Up to three ADDF-Harrington Scholar awards are made each year through a competitive selection process. Amount: Up to $600,000 over two years. Deadline for Letters of Intent: April 12, 2019; Full proposal deadline (invitation only): July 19, 2019.
     
  • Alzheimer's Research UK and the Dementia Consortium: Dementia Consortium Funding. This supports research projects that aim to provide validation of targets for the treatment of dementia or explore the tractability of the target for drug discovery. Promising targets are moved towards the clinic through the successful licence of these projects to industrial partners with the ultimate aim of bringing benefit to patients. Projects are collaborative in nature, with involvement from the consortium members in devising the final project plan. Projects are sought that focus on novel molecular targets in neurodegenerative diseases. Scientists at academic institutions worldwide may apply. Grants are typically worth between £100,000 and £250,000 each over two to three years. Up to £500,000 may be awarded in exceptional cases. Deadline for Expressions of Interest: June 26, 2019.
     
  • British Heart Foundation: Big Beat Challenge. The Big Beat Challenge is a global competition that will culminate in a single research award of up to £30 million to an international multi-disciplinary team, which has identified and proposed a transformational solution to a significant problem in heart and circulatory disease. It is a challenge to scientists, clinicians, innovators and entrepreneurs to look beyond incremental gains and accelerate research breakthroughs that could transform lives across the globe. Teams must be highly collaborative, mobilising knowledge, skills and resources from multiple disciplines and… more » sectors. Proposals must seek to address a specific area of unmet need with a clear route to patient benefit that is as comprehensible to the general public as it is to patients, healthcare professionals and researchers. Teams must demonstrate that their project would not be possible without the proposed scale of funding. Deadline for Stage 1 applications: June 14, 2019.
     
  • Action on Hearing Loss: Translational Research Initiative for Hearing (TRIH) Grants. The scope of the Translational Research Initiative for Hearing call varies from year to year. This year, applications can include: 
    Small molecule, gene or cell-based approaches for the treatment of hearing loss or tinnitus. Amount: Up to £100,000 per year for up to three years. Applicants may be from any country. Deadline for Expressions of Interest: April 7, 2019.
     
  • National Center for Responsible Gambling (NCRG): Grants for Research on Gambling Disorders. 
    • Seed Grants. Applicants may request up to USD $30,000 in direct costs plus 15 percent indirect costs for one year. Deadline for applications: August 1, 2019
    • Large Grants: Large Grants support two-year projects. Applicants may request up to USD $75,000 per year in direct costs and up to 15 percent in indirect costs. Deadline for Letters of Intent: June 3, 2019; Applications deadline: September 3, 2019.
       

February 28, 2019
 

  • CIHR Upcoming Webinars:
  • Cannabis Innovation Summit 
    Presented by the University of Toronto together with its affiliated hospital partners and the Toronto Cannabis & Cannabinoid Research Consortium (TC3)
    The Summit will focus on the drug development of cannabis and cannabinoid related therapies and drug delivery mechanisms from discovery to innovation. It will explore various clinical applications and trials around the assessment of the safety and efficacy of cannabis as a medicine and discuss important societal issues as it relates to mental and body health. This event will also bring together scientists, government officials, policy-makers, research funding organizations and industry partners who are interested in research and innovation in this field.  Read the full agenda. 
    Date: Thursday April 4th, 2019
    Time: 8:00am – 2:30pm

    Location: MaRS Auditorium, Lower Concourse, 101 College Street, Toronto
    Please register here for the Cannabis Innovation Summit
    RBC Series with Daniele Piomelli 
     
  • NIH/CIHR Pre-launch Announcement: Concussion Research Funding Opportunity. “Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (CWOW)”. The objective of this initiative is to support research on discovering and/or validating biological measures to be used for assessing, prognosing, and monitoring recovery of adolescents who either clinically present with or are at risk for developing prolonged/persistent concussive symptoms following exposure to repetitive head impacts and/or concussion. These biological measures should then be incorporated into risk stratification algorithms to inform clinical care and patient stratification for future clinical trials. A key component of this FO will be the broad sharing of clinical, neuroimaging, physiological, and biospecimen data to further advance research in the area of persistent concussive symptoms in early and middle adolescent (EMA; ages 11-17 years old) populations. CIHR's investment will be limited to pediatric concussion researchers based in Canada. It is expected that one grant / research team would be funded by CIHR, with a maximum contribution of $250K/year per grant, for up to 5 years. Deadline for applications to both NIH and CIHR: April 10, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • The Bill & Melinda Gates Foundation: Global Challenges - Solving Global health & Development Problems for Those Most in Need. 
  • The Foundation for Prader-Willi Research (FPWR): RFA - Brain Imaging Studies in Individuals with PWS. FPWR is interested in proposals that apply cutting-edge functional brain imaging to examine connectivity in individuals with PWS at specific developmental stages or across development. The scope of this RFA is broad, encompassing descriptive studies or focusing on the neurobiological correlates underlying phenotypic abnormalities characteristics of PWS such as hyperphagia and mental health. Amount: Up to $100,000 USD in direct costs for the initial year of support, with the possibility of a second year of funding upon competitive renewal. Deadline for Letters of Intent: March 4, 2019; Deadline for full proposals: May 6, 2019.
     
  • TS Alliance: Research Grants Program - tuberous sclerosis complex. Most TS Alliance research grants support small, focused projects that allow investigators to develop preliminary data to compete for funding from larger organizations such as the National Institutes of Health (NIH).  Other TS Alliance research grants support postdoctoral fellowships to encourage young investigators to engage in TSC research.  Many of these investigators will continue to pursue TSC research when they establish their own independent laboratories. Amount: Up to USD $150,000 over two years. Deadline for Letters of Intent: April 8, 2019. 
     
  • Sanfilippo Children's Foundation: Project Grants.  The Sanfilippo Children's Foundation is currently calling for expressions of interest for 1) Translational Research Grants (up to AUD $500K/year for up to 3 years) and 2) Incubator Grants (up to AUD $90K for 1 year if salary is included in costing, otherwise up to AUD $25K). Deadline for Expressions of Interest: March 25, 2019.
     
  • Alzheimer's Association: International Research Grant Program. 
    Deadline for Letters of Intent: March 3, 2019; Application deadline: April 29, 2019.
    • Research Grant (and Research Grant to Promote Diversity)
    • Research Grant - New to the Field
    • Research Fellowship (and Research Fellowship to Promote Diversity)
    • Clinician Scientist Fellowship (and Clinician Scientist Fellowship to Promote Diversity)
    • Zenith Fellows Award

February 18, 2019
 

  • SickKids Foundation: New Investigator Research Grants.  This program provides support to child health researchers early in their careers so that they can compete with more senior investigators for research grants from other funders. Grant recipients may obtain up to three years of support for research in the biomedical, clinical, health systems and services, population and public health sectors. Amount: Up to $100,000 per year for up to 3 years. 
    Deadline for applications: April 22, 2019. 
    Community Conference Grants bring together families with researchers and clinicians for medical presentations, workshops, symposia and family-oriented discussions. The conference helps to ensure families receive access to the most up-to-date information regarding their children's health. The grant will support events which are organized by and/or for families with children with health challenges, including, but not limited to children with acute illness, chronic illness and disabilities. Amount: Up to $5,000 annually. Deadline for applications: May 31 or September 30, 2019.
     
  • Cancer Research Society: Translational Research Partnership Program. The goal of this program is to support collaborative and pivotal translational research projects. Amount: Up to a maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society. Projects must be translational research and may include clinical trial studies, aim the development of a therapeutic and/or novel technologies, and have excellent preliminary data to support the proposed project. There is no deadline associated with this program. Letters of Intent from applicants with high potential projects will be invited to submit an official application for funding, which is then peer-reviewed. 
     
  • Simons Foundation Autism Research Initiative: SFARI Summer 2019 Pilot Award. The goal of the Pilot Award is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. To get a better understanding of SFARI’s different RFAs and whether the Pilot Award may be the best mechanism to support your project, please read their blog post “SFARI RFA reboot: Why, what and how". Amount: Up to USD $300,000 over a maximum of 2 years. Deadline for applications: April 18, 2019. 
     

February 5, 2019
 

  • Mitacs Globalink Research Award - Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
  • Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca
     
  • Cancer Research Society: 2019 Scholarships for the Next Generation of Scientists. This initiative aims at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal. Deadline for submissions: April 26, 2019.
    • Part 1: Postdoctoral Salary Award -  1 year -  $50,000 (with a possibility of extending this award for a maximum period of 6 months)
    • Part 2: Operating Grant  -   2 years - $120,000 ($60,000/year)
       
  • The Ontario HIV Treatment Network (OHTN), Endgame Funding Program: Community-Based Research and Evaluation  (CBR&E) Awards. The objective of the CBR & E Funding is to assist communities by supporting the production and discovery of knowledge through community-based research; and the use of evidence to drive programming through participatory program evaluation. Amount: $25,000 - $50,000 for one year. Application deadlines: March 1, June 7, September 6 and December 6, 2019.
    OHTN's Strategic Plan to 2026: HIV Endgame.
     
  • Genome Canada: Genomic Applications Partnership Program (GAPP) Round 15 & 16. Precision Health Initiative - Rare Diseases: Clinical Implementation Projects.  Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. In order to initiate this ambitious program, Genome Canada is encouraging the submission of projects to the GAPP. For more details, please see here. The GAPP funds public-private research collaborations focused on downstream research and development (R&D) projects that address real world opportunities and challenges defined by "Receptor" organizations such as industry, government, or not-for-profit entities. These organizations should be committed to commercializing or implementing the outcomes of the project. Applicants interested in applying are encouraged to contact Helen Petropoulos at Ontario Genomics (OG). For information on the application process, please visit the GAPP homepage, or the UofT funding opportunity
    Deadlines for Expressions of Interest (EOIs):
    • Round 15: Draft EOI is due to RSO and OG on Feb 19, 2019; Final EOIs are due to RSO April 1st via MRA to meet OG's deadline of April 8, 2019 
    • Round 16: Draft EOI is due to RSO and OG on May 20, 2019; Final EOIs are due to RSO July 2nd via MRA to meet OG's deadline of July 9, 2019 
       
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • Alzheimer's Drug Discovery Foundation (ADDF): Funding Opportunities.  The 2019 deadlines for LOIs are January 18; April 12, July 19, or October 11, 2019.
    • Program to Accelerate Clinical Trials (PACT). This RFP funds early-stage clinical trials through phase 2 for novel drug candidates, proof-of-concept trials in patients for repurposed/repositioned drugs, and regulatory studies for IND/CTA preclinical packages and drug manufacturing for later stage trials. Average amount: Up to USD $5M.
    • Neuroimaging and CSF Biomarker Development. This RFP supports the development and validation of neuroimaging and CSF biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging. Average amount: USD $150,000-$600,000.
    • Prevention Beyond the Pipeline. This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Amount: USD $50,000-$100,000 for epidemiological analyses; USD Up to $3 million for clinical trials.
    • Drug Discovery. This RFP supports programs advancing lead molecules to clinical candidate selection or building preclinical evidence in relevant animal models for repurposed/repositioned drugs. Average amount: USD $150,000-$600,000.

       
  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: March 1, 2019; June 1, 2019; and September 1, 2019.